Clinical Trials · NCT07531251
Clinical Trial in Patients With Barth Syndrome- 4TAZPower
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 48
- Start date
- Jun 2026
- Locations
- 2 sites, United States, United Kingdom
- Primary endpoint
- Primary Efficacy End Point